vs

Side-by-side financial comparison of Dexcom (DXCM) and PATRICK INDUSTRIES INC (PATK). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $924.2M, roughly 1.4× PATRICK INDUSTRIES INC). Dexcom runs the higher net margin — 21.2% vs 3.1%, a 18.1% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 9.2%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.5%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

DXCM vs PATK — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.4× larger
DXCM
$1.3B
$924.2M
PATK
Growing faster (revenue YoY)
DXCM
DXCM
+12.4% gap
DXCM
21.6%
9.2%
PATK
Higher net margin
DXCM
DXCM
18.1% more per $
DXCM
21.2%
3.1%
PATK
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-0.5%
PATK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
PATK
PATK
Revenue
$1.3B
$924.2M
Net Profit
$267.3M
$29.1M
Gross Margin
62.9%
23.0%
Operating Margin
25.6%
6.2%
Net Margin
21.2%
3.1%
Revenue YoY
21.6%
9.2%
Net Profit YoY
153.6%
99.7%
EPS (diluted)
$0.67
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
PATK
PATK
Q1 26
$1.3B
Q4 25
$1.3B
$924.2M
Q3 25
$1.2B
$975.6M
Q2 25
$1.2B
$1.0B
Q1 25
$1.0B
$1.0B
Q4 24
$1.1B
$846.1M
Q3 24
$994.2M
$919.4M
Q2 24
$1.0B
$1.0B
Net Profit
DXCM
DXCM
PATK
PATK
Q1 26
$267.3M
Q4 25
$267.3M
$29.1M
Q3 25
$283.8M
$35.3M
Q2 25
$179.8M
$32.4M
Q1 25
$105.4M
$38.2M
Q4 24
$151.7M
$14.6M
Q3 24
$134.6M
$40.9M
Q2 24
$143.5M
$47.9M
Gross Margin
DXCM
DXCM
PATK
PATK
Q1 26
62.9%
Q4 25
62.9%
23.0%
Q3 25
60.5%
22.6%
Q2 25
59.5%
23.9%
Q1 25
56.9%
22.8%
Q4 24
58.9%
22.1%
Q3 24
59.7%
23.1%
Q2 24
62.4%
22.8%
Operating Margin
DXCM
DXCM
PATK
PATK
Q1 26
25.6%
Q4 25
25.6%
6.2%
Q3 25
20.1%
6.8%
Q2 25
18.4%
8.3%
Q1 25
12.9%
6.5%
Q4 24
17.0%
4.7%
Q3 24
15.3%
8.1%
Q2 24
15.7%
8.3%
Net Margin
DXCM
DXCM
PATK
PATK
Q1 26
21.2%
Q4 25
21.2%
3.1%
Q3 25
23.5%
3.6%
Q2 25
15.5%
3.1%
Q1 25
10.2%
3.8%
Q4 24
13.6%
1.7%
Q3 24
13.5%
4.4%
Q2 24
14.3%
4.7%
EPS (diluted)
DXCM
DXCM
PATK
PATK
Q1 26
$0.67
Q4 25
$0.67
$0.82
Q3 25
$0.70
$1.01
Q2 25
$0.45
$0.96
Q1 25
$0.27
$1.11
Q4 24
$0.37
$-1.44
Q3 24
$0.34
$1.80
Q2 24
$0.35
$2.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
PATK
PATK
Cash + ST InvestmentsLiquidity on hand
$917.7M
$26.4M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$2.7B
$1.2B
Total Assets
$6.3B
$3.1B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
PATK
PATK
Q1 26
$917.7M
Q4 25
$917.7M
$26.4M
Q3 25
$1.8B
$20.7M
Q2 25
$1.2B
$22.0M
Q1 25
$904.9M
$86.6M
Q4 24
$606.1M
$33.6M
Q3 24
$621.2M
$52.6M
Q2 24
$939.2M
$44.0M
Total Debt
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
$1.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
PATK
PATK
Q1 26
$2.7B
Q4 25
$2.7B
$1.2B
Q3 25
$2.7B
$1.2B
Q2 25
$2.6B
$1.1B
Q1 25
$2.3B
$1.1B
Q4 24
$2.1B
$1.1B
Q3 24
$2.0B
$1.1B
Q2 24
$2.4B
$1.1B
Total Assets
DXCM
DXCM
PATK
PATK
Q1 26
$6.3B
Q4 25
$6.3B
$3.1B
Q3 25
$7.5B
$3.1B
Q2 25
$7.3B
$3.1B
Q1 25
$6.8B
$3.2B
Q4 24
$6.5B
$3.0B
Q3 24
$6.4B
$3.1B
Q2 24
$6.8B
$3.0B
Debt / Equity
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
1.10×
Q3 25
Q2 25
Q1 25
Q4 24
1.18×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
PATK
PATK
Operating Cash FlowLast quarter
$130.8M
Free Cash FlowOCF − Capex
$112.7M
FCF MarginFCF / Revenue
12.2%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
4.50×
TTM Free Cash FlowTrailing 4 quarters
$246.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
$294.0M
$130.8M
Q3 25
$659.9M
$9.1M
Q2 25
$303.0M
$149.4M
Q1 25
$183.8M
$40.1M
Q4 24
$301.4M
$102.7M
Q3 24
$199.5M
$51.5M
Q2 24
$279.4M
$137.5M
Free Cash Flow
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
$192.1M
$112.7M
Q3 25
$579.4M
$-17.2M
Q2 25
$208.9M
$131.1M
Q1 25
$96.8M
$19.9M
Q4 24
$176.8M
$77.2M
Q3 24
$88.3M
$33.7M
Q2 24
$213.3M
$120.6M
FCF Margin
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
15.3%
12.2%
Q3 25
47.9%
-1.8%
Q2 25
18.1%
12.5%
Q1 25
9.3%
2.0%
Q4 24
15.9%
9.1%
Q3 24
8.9%
3.7%
Q2 24
21.2%
11.9%
Capex Intensity
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
8.1%
2.0%
Q3 25
6.7%
2.7%
Q2 25
8.1%
1.7%
Q1 25
8.4%
2.0%
Q4 24
11.2%
3.0%
Q3 24
11.2%
1.9%
Q2 24
6.6%
1.7%
Cash Conversion
DXCM
DXCM
PATK
PATK
Q1 26
Q4 25
1.10×
4.50×
Q3 25
2.33×
0.26×
Q2 25
1.69×
4.61×
Q1 25
1.74×
1.05×
Q4 24
1.99×
7.05×
Q3 24
1.48×
1.26×
Q2 24
1.95×
2.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

Related Comparisons